Cargando…
Preclinical Toxicity and Immunogenicity of a COVID-19 Vaccine (ZF2001) in Cynomolgus Monkeys
Although the new coronavirus disease 2019 (COVID-19) outbreak occurred in late 2019, it is still endemic worldwide, and has become a global public health problem. Vaccination against SARS-CoV-2 is considered to be the most effective intervention to prevent the spread of COVID-19. ZF2001 is a recombi...
Autores principales: | Yang, Hongzhong, Pan, Wei, Chen, Guoyu, Huang, Enqi, Lu, Qijiong, Chen, Yunxiang, Chen, Ying, Yang, Zhengbiao, Wen, Lei, Zhang, Siming, Xu, Cong, Lv, Wanqiang, Dai, Lianpan, Wu, Changwei, Zhang, Lijiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9781319/ https://www.ncbi.nlm.nih.gov/pubmed/36560490 http://dx.doi.org/10.3390/vaccines10122080 |
Ejemplares similares
-
Developmental and reproductive toxicity of a recombinant protein subunit COVID-19 vaccine (ZF2001) in rats
por: Song, Yisheng, et al.
Publicado: (2023) -
Repeat-dose toxicity study of human umbilical cord mesenchymal stem cells in cynomolgus monkeys by intravenous and subcutaneous injection
por: Pan, Wei, et al.
Publicado: (2023) -
Neutralisation of ZF2001-elicited antisera to SARS-CoV-2 variants
por: Zhao, Xin, et al.
Publicado: (2021) -
Omicron SARS-CoV-2 Neutralization from Inactivated and ZF2001 Vaccines
por: Zhao, Xin, et al.
Publicado: (2022) -
A tandem-repeat dimeric RBD protein-based covid-19 vaccine zf2001 protects mice and nonhuman primates
por: An, Yaling, et al.
Publicado: (2022)